BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 37506784)

  • 1. Circulating extracellular vesicles derived from tumor endothelial cells hijack the local and systemic anti-tumor immune response: Role of mTOR/G-CSF pathway.
    Koni M; Lopatina T; Grange C; Sarcinella A; Cedrino M; Bruno S; Buffolo F; Femminò S; Camussi G; Brizzi MF
    Pharmacol Res; 2023 Sep; 195():106871. PubMed ID: 37506784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum-derived extracellular vesicles from breast cancer patients contribute to differential regulation of T-cell-mediated immune-escape mechanisms in breast cancer subtypes.
    Graham R; Gazinska P; Zhang B; Khiabany A; Sinha S; Alaguthurai T; Flores-Borja F; Vicencio J; Beuron F; Roxanis I; Matkowski R; Liam-Or R; Tutt A; Ng T; Al-Jamal KT; Zhou Y; Irshad S
    Front Immunol; 2023; 14():1204224. PubMed ID: 37441083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allogeneic tumor cell-derived extracellular vesicles stimulate CD8 T cell response in colorectal cancer.
    Gates TJ; Wangmo D; Zhao X; Subramanian S
    Mol Ther Oncolytics; 2023 Dec; 31():100727. PubMed ID: 37822487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular Determinants Involved in the Docking and Uptake of Tumor-Derived Extracellular Vesicles: Implications in Cancer.
    Clares-Pedrero I; Rocha-Mulero A; Palma-Cobo M; Cardeñes B; Yáñez-Mó M; Cabañas C
    Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oncogenic mTOR signalling recruits myeloid-derived suppressor cells to promote tumour initiation.
    Welte T; Kim IS; Tian L; Gao X; Wang H; Li J; Holdman XB; Herschkowitz JI; Pond A; Xie G; Kurley S; Nguyen T; Liao L; Dobrolecki LE; Pang L; Mo Q; Edwards DP; Huang S; Xin L; Xu J; Li Y; Lewis MT; Wang T; Westbrook TF; Rosen JM; Zhang XH
    Nat Cell Biol; 2016 Jun; 18(6):632-44. PubMed ID: 27183469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous injection of tumor extracellular vesicles suppresses tumor growth by reducing the regulatory T cell phenotype.
    Kobayashi S; Kondo N; Tomiyama T; Nakamura N; Masuda M; Matsumoto Y; Honzawa Y; Tahara T; Ikeura T; Fukui T; Okazaki K; Naganuma M
    Cancer Immunol Immunother; 2023 Nov; 72(11):3651-3664. PubMed ID: 37597014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blockade of CD93 in pleural mesothelial cells fuels anti-lung tumor immune responses.
    Zhang C; Nan X; Zhang B; Wu H; Zeng X; Song Z; Li S; Wang J; Xie S; Zhang G; Xiu H; Wang J; Guo J; Wang P; Cai Z; Zhen Y; Shen Y
    Theranostics; 2024; 14(3):1010-1028. PubMed ID: 38250037
    [No Abstract]   [Full Text] [Related]  

  • 8. Novel Personalized Cancer Vaccine Using Tumor Extracellular Vesicles with Attenuated Tumorigenicity and Enhanced Immunogenicity.
    Han J; Kim S; Hwang YH; Kim SA; Lee Y; Kim J; Cho S; Woo J; Jeong C; Kwon M; Nam GH; Kim IS
    Adv Sci (Weinh); 2024 Apr; ():e2308662. PubMed ID: 38666427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A fatal affair: Circulating tumor cell relationships that shape metastasis.
    Ozimski LL; Gremmelspacher D; Aceto N
    iScience; 2021 Sep; 24(9):103073. PubMed ID: 34568794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dibenzocyclooctadiene lignans from the family Schisandraceae: A review of phytochemistry, structure-activity relationship, and hepatoprotective effects.
    Liu SQ; Yang YP; Hussain N; Jian YQ; Li B; Qiu YX; Yu HH; Wang HZ; Wang W
    Pharmacol Res; 2023 Sep; 195():106872. PubMed ID: 37516152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apolipoprotein B compared with low-density lipoprotein cholesterol in the atherosclerotic cardiovascular diseases risk assessment.
    Galimberti F; Casula M; Olmastroni E
    Pharmacol Res; 2023 Sep; 195():106873. PubMed ID: 37517561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The neuromedin U system: Pharmacological implications for the treatment of obesity and binge eating behavior.
    Botticelli L; Micioni Di Bonaventura E; Del Bello F; Giorgioni G; Piergentili A; Quaglia W; Bonifazi A; Cifani C; Micioni Di Bonaventura MV
    Pharmacol Res; 2023 Sep; 195():106875. PubMed ID: 37517560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ENPP2 inhibitor improves proliferation in AOM/DSS-induced colorectal cancer mice via remodeling the gut barrier function and gut microbiota composition.
    Yan J; Duan W; Gao Q; Mao T; Wang M; Duan J; Li J
    Pharmacol Res; 2023 Sep; 195():106877. PubMed ID: 37524154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arrest of mouse preterm labor until term delivery by combination therapy with atosiban and mundulone, a natural product with tocolytic efficacy.
    Siricilla S; Hansen CJ; Rogers JH; De D; Simpson CL; Waterson AG; Sulikowski GA; Crockett SL; Boatwright N; Reese J; Paria BC; Newton J; Herington JL
    Pharmacol Res; 2023 Sep; 195():106876. PubMed ID: 37536638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breast Cancer-Secreted Factors Promote Lung Metastasis by Signaling Systemically to Induce a Fibrotic Premetastatic Niche.
    Cohen N; Mundhe D; Deasy SK; Adler O; Ershaid N; Shami T; Levi-Galibov O; Wassermann R; Scherz-Shouval R; Erez N
    Cancer Res; 2023 Oct; 83(20):3354-3367. PubMed ID: 37548552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SGLT2i: Therapeutic options or contributing factors of contrast-induced acute kidney injury in the setting of non-diabetes?
    Wu J; Cai H; Xia J; Zhang T; Yan J; Shao X; Wang AY; Shen J; Mou S
    Pharmacol Res; 2023 Sep; 195():106883. PubMed ID: 37544050
    [No Abstract]   [Full Text] [Related]  

  • 17. New therapies towards a better glycemic control in youths with type 1 diabetes.
    Cardona-Hernandez R; Dôvc K; Biester T; Ekhlaspour L; Macedoni M; Tauschmann M; Mameli C
    Pharmacol Res; 2023 Sep; 195():106882. PubMed ID: 37543096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cuyun Recipe ameliorates pregnancy loss by regulating macrophage polarization and hypercoagulable state during the peri-implantation period in an ovarian hyperstimulation mouse model.
    Zhu W; Xu M; Zhu M; Song Y; Zhang J; Zheng C
    Phytomedicine; 2023 Oct; 119():154974. PubMed ID: 37523838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Demethylzeylasteral targets lactate to suppress the tumorigenicity of liver cancer stem cells: It is attributed to histone lactylation?
    Gong H; Xu HM; Ma YH; Zhang DK
    Pharmacol Res; 2023 Aug; 194():106869. PubMed ID: 37517563
    [No Abstract]   [Full Text] [Related]  

  • 20. Reply to the letter titled: Demethylzeylasteral targets lactate to suppress the tumorigenicity of liver cancer stem cells: Is it attributed to histone lactylation?
    Wang C; Feng F; Pan L; Xu K
    Pharmacol Res; 2023 Aug; 194():106868. PubMed ID: 37517562
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.